4//SEC Filing
Linscott Walt Addison 4
Accession 0001493152-22-002550
CIK 0001857044other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:30 PM ET
Size
5.5 KB
Accession
0001493152-22-002550
Insider Transaction Report
Form 4
Linscott Walt Addison
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-26+45,850→ 45,850 totalExercise: $4.90Exp: 2032-01-26→ Common Stock (45,850 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on January 26, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001648585
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:30 PM ET
- Size
- 5.5 KB